Proteomic changes resulting from gene copy number variations in cancer cells

PLoS Genetics

Volumn 6, Issue 9, 2010, Pages

  Geiger, Tamar ^a   Cox, Juergen ^a   Mann, Matthias ^a  

^a MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; EPIDERMAL GROWTH FACTOR RECEPTOR 2; MESSENGER RNA; ONCOPROTEIN; PROTEIN KINASE B;

ACCURACY; ARTICLE; CANCER CELL CULTURE; CELL TRANSFORMATION; CHROMOSOME ABERRATION; CONTROLLED STUDY; COPY NUMBER VARIATION; GENE DOSAGE; GENE EXPRESSION; GENE FUNCTION; GENE OVEREXPRESSION; GENETIC ALGORITHM; GENETIC VARIABILITY; GENOMICS; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; PROTEOMICS; SINGLE NUCLEOTIDE POLYMORPHISM;

BREAST NEOPLASMS; CELL LINE; CHROMOSOME ABERRATIONS; DATABASES, GENETIC; DNA COPY NUMBER VARIATIONS; FEMALE; GENE AMPLIFICATION; GENE DOSAGE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, NEOPLASM; HUMANS; MULTIPROTEIN COMPLEXES; NEOPLASM PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN STABILITY; PROTEOME; PROTEOMICS; RNA, MESSENGER;

EID: 78049443323     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/journal.pgen.1001090     Document Type: Article

References (47)

1. Albertson DG (2006) Gene amplification in cancer. Trends Genet 22: 447-455.
2. Ganem NJ, Storchova Z, Pellman D (2007) Tetraploidy, aneuploidy and cancer. Curr Opin Genet Dev 17: 157-162.
3. Torres EM, Sokolsky T, Tucker CM, Chan LY, Boselli M, et al. (2007) Effects of aneuploidy on cellular physiology and cell division in haploid yeast. Science 317: 916-924.
4. Williams BR, Prabhu VR, Hunter KE, Glazier CM, Whittaker CA, et al. (2008) Aneuploidy affects proliferation and spontaneous immortalization in mammalian cells. Science 322: 703-709.
5. Beroukhim R, Mermel CH, Porter D, Wei G, Raychaudhuri S, et al. The landscape of somatic copy-number alteration across human cancers. Nature 463: 899-905.
6. Bignell GR, Greenman CD, Davies H, Butler AP, Edkins S, et al. Signatures of mutation and selection in the cancer genome. Nature 463: 893-898.
7. Reyal F, Stransky N, Bernard-Pierrot I, Vincent-Salomon A, de Rycke Y, et al. (2005) Visualizing chromosomes as transcriptome correlation maps: evidence of chromosomal domains containing co-expressed genes-a study of 130 invasive ductal breast carcinomas. Cancer Res 65: 1376-1383.
8. Zhou Y, Luoh SM, Zhang Y, Watanabe C, Wu TD, et al. (2003) Genome-wide identification of chromosomal regions of increased tumor expression by transcriptome analysis. Cancer Res 63: 5781-5784.
9. Crawley JJ, Furge KA (2002) Identification of frequent cytogenetic aberrations in hepatocellular carcinoma using gene-expression microarray data. Genome Biol 3: RESEARCH0075.
10. Hyman E, Kauraniemi P, Hautaniemi S, Wolf M, Mousses S, et al. (2002) Impact of DNA amplification on gene expression patterns in breast cancer. Cancer Res 62: 6240-6245.
11. Furge KA, Dykema KJ, Ho C, Chen X (2005) Comparison of array-based comparative genomic hybridization with gene expression-based regional expression biases to identify genetic abnormalities in hepatocellular carcinoma. BMC Genomics 6: 67.
12. Mano MS, Rosa DD, De Azambuja E, Ismael GF, Durbecq V (2007) The 17q12-q21 amplicon: Her2 and topoisomerase-IIalpha and their importance to the biology of solid tumours. Cancer Treat Rev 33: 64-77.
13. Lengauer C, Kinzler KW, Vogelstein B (1998) Genetic instabilities in human cancers. Nature 396: 643-649.
14. Cox J, Mann M (2008) MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat Biotechnol 26: 1367-1372.
15. Ong SE, Blagoev B, Kratchmarova I, Kristensen DB, Steen H, et al. (2002) Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol Cell Proteomics 1: 376-386.
16. Aebersold R, Mann M (2003) Mass spectrometry-based proteomics. Nature 422: 198-207.
17. Makarov A, Denisov E, Kholomeev A, Balschun W, Lange O, et al. (2006) Performance evaluation of a hybrid linear ion trap/orbitrap mass spectrometer. Anal Chem 78: 2113-2120.
18. de Godoy LM, Olsen JV, Cox J, Nielsen ML, Hubner NC, et al. (2008) Comprehensive mass-spectrometry-based proteome quantification of haploid versus diploid yeast. Nature 455: 1251-1254.
19. Graumann J, Hubner NC, Kim JB, Ko K, Moser M, et al. (2008) Stable isotope labeling by amino acids in cell culture (SILAC) and proteome quantitation of mouse embryonic stem cells to a depth of 5,111 proteins. Mol Cell Proteomics 7: 672-683.
20. Pollack JR, Sorlie T, Perou CM, Rees CA, Jeffrey SS, et al. (2002) Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors. Proc Natl Acad Sci U S A 99: 12963-12968.
21. Stransky N, Vallot C, Reyal F, Bernard-Pierrot I, de Medina SG, et al. (2006) Regional copy number-independent deregulation of transcription in cancer. Nat Genet 38: 1386-1396.
22. Chin SF, Teschendorff AE, Marioni JC, Wang Y, Barbosa-Morais NL, et al. (2007) High-resolution aCGH and expression profiling identifies a novel genomic subtype of ER negative breast cancer. Genome Biol 8: R215.
23. Naylor TL, Greshock J, Wang Y, Colligon T, Yu QC, et al. (2005) High resolution genomic analysis of sporadic breast cancer using array-based comparative genomic hybridization. Breast Cancer Res 7: R1186-1198.
24. Lam YW, Lamond AI, Mann M, Andersen JS (2007) Analysis of nucleolar protein dynamics reveals the nuclear degradation of ribosomal proteins. Curr Biol 17: 749-760.
25. Futreal PA, Coin L, Marshall M, Down T, Hubbard T, et al. (2004) A census of human cancer genes. Nat Rev Cancer 4: 177-183.
26. Glynn RW, Miller N, Kerin MJ. 17q12-21 - The pursuit of targeted therapy in breast cancer. Cancer Treat Rev.
27. Ginestier C, Adelaide J, Goncalves A, Repellini L, Sircoulomb F, et al. (2007) ERBB2 phosphorylation and trastuzumab sensitivity of breast cancer cell lines. Oncogene 26: 7163-7169.
28. Valabrega G, Montemurro F, Aglietta M (2007) Trastuzumab: mechanism of action, resistance and future perspectives in HER2-overexpressing breast cancer. Ann Oncol 18: 977-984.
29. Nadler Y, Gonzalez AM, Camp RL, Rimm DL, Kluger HM, et al. Growth factor receptor-bound protein-7 (Grb7) as a prognostic marker and therapeutic target in breast cancer. Ann Oncol 21: 466-473.
30. Donnellan R, Chetty R (1998) Cyclin D1 and human neoplasia. Mol Pathol 51: 1-7.
31. Gautschi O, Ratschiller D, Gugger M, Betticher DC, Heighway J (2007) Cyclin D1 in non-small cell lung cancer: a key driver of malignant transformation. Lung Cancer 55: 1-14.
32. Roy PG, Pratt N, Purdie CA, Baker L, Ashfield A, et al. (2009) High CCND1 amplification identifies a group of poor prognosis women with estrogen receptor positive breast cancer. Int J Cancer.
33. Serra-Pages C, Kedersha NL, Fazikas L, Medley Q, Debant A, et al. (1995) The LAR transmembrane protein tyrosine phosphatase and a coiled-coil LAR-interacting protein co-localize at focal adhesions. Embo J 14: 2827-2838.
34. Luo ML, Shen XM, Zhang Y, Wei F, Xu X, et al. (2006) Amplification and overexpression of CTTN (EMS1) contribute to the metastasis of esophageal squamous cell carcinoma by promoting cell migration and anoikis resistance. Cancer Res 66: 11690-11699.
35. Strasser A, Newton K (1999) FADD/MORT1, a signal transducer that can promote cell death or cell growth. Int J Biochem Cell Biol 31: 533-537.
36. Nicholson KM, Anderson NG (2002) The protein kinase B/Akt signalling pathway in human malignancy. Cell Signal 14: 381-395.
37. Toh Y, Nicolson GL (2009) The role of the MTA family and their encoded proteins in human cancers: molecular functions and clinical implications. Clin Exp Metastasis 26: 215-227.
38. Heyen CA, Tagliabracci VS, Zhai L, Roach PJ (2009) Characterization of mouse UDP-glucose pyrophosphatase, a Nudix hydrolase encoded by the Nudt14 gene. Biochem Biophys Res Commun 390: 1414-1418.
39. Chhabra ES, Higgs HN (2006) INF2 Is a WASP homology 2 motif-containing formin that severs actin filaments and accelerates both polymerization and depolymerization. J Biol Chem 281: 26754-26767.
40. Weiskirchen R, Gunther K (2003) The CRP/MLP/TLP family of LIM domain proteins: acting by connecting. Bioessays 25: 152-162.
41. Fraga MF, Herranz M, Espada J, Ballestar E, Paz MF, et al. (2004) A mouse skin multistage carcinogenesis model reflects the aberrant DNA methylation patterns of human tumors. Cancer Res 64: 5527-5534.
42. Wisniewski JR, Zougman A, Nagaraj N, Mann M (2009) Universal sample preparation method for proteome analysis. Nat Methods 6: 359-362.
43. Hubner NC, Ren S, Mann M (2008) Peptide separation with immobilized pI strips is an attractive alternative to in-gel protein digestion for proteome analysis. Proteomics 8: 4862-4872.
44. Rappsilber J, Ishihama Y, Mann M (2003) Stop and go extraction tips for matrix-assisted laser desorption/ionization, nanoelectrospray, and LC/MS sample pretreatment in proteomics. Anal Chem 75: 663-670.
45. Olsen JV, de Godoy LM, Li G, Macek B, Mortensen P, et al. (2005) Parts per million mass accuracy on an Orbitrap mass spectrometer via lock mass injection into a C-trap. Mol Cell Proteomics 4: 2010-2021.
46. Cox J, Matic I, Hilger M, Nagaraj N, Selbach M, et al. (2009) A practical guide to the MaxQuant computational platform for SILAC-based quantitative proteomics. Nat Protoc 4: 698-705.
47. Jensen LJ, Kuhn M, Stark M, Chaffron S, Creevey C, et al. (2009) STRING 8- a global view on proteins and their functional interactions in 630 organisms. Nucleic Acids Res 37: D412-416.